scorecardresearch
Follow Us:
Saturday, June 25, 2022

25 countries in queue for ‘Made in India’ COVID-19 vaccine: Jaishankar

He said there are three categories of countries which are keen to get the vaccine from India- poor, price sensitive nations and other countries which directly deal with pharmaceutical companies that make the antidote.

By: PTI | Amaravati |
Updated: February 6, 2021 3:02:10 pm
S Jaishankar, COVID-19 vaccine, Coronavirus vaccine, External Affairs Minister, Covaxin vaccine, Bharat Biotech, Covishield of Oxford, Serum Institute of India, Prime Minister Narendra Modi, india news, indian vaccineExternal Affairs Minister S Jaishankar. (File)

India has so far supplied COVID-19 vaccine to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister S Jaishankar said here on Saturday.

He said there are three categories of countries which are keen to get the vaccine from India- poor, price sensitive nations and other countries which directly deal with pharmaceutical companies that make the antidote.

“I think right now we have already supplied to about 15 countries (as per my recollection). I would say there would be another about 25 countries which are at different stages in the pipeline. But what it has done is today it has put India on the map of the world,” Jaishankar told reporters in a press conference.

The minister said some poor countries are being supplied the vaccine on a grant basis while some nations wanted it on par with the price that the Indian Government pays to the vaccine makers.

Best of Express Premium
In 1978, it was Sharad Pawar who had led a rebel group and toppled Mahara...Premium
Explained: How the billion-dollar automobile industry is changing, courte...Premium
Need to accelerate reform pace in energy transition: CEO, Niti AayogPremium
Top six nutrients to enhance the longevity of your brainPremium

Some countries have direct contracts with the Indian vaccine producing companies and have negotiated commercially, he said.

The Centre has already given the nod for two COVID-19 vaccines– Covaxin of city-based Bharat Biotech and Covishield of Oxford, being manufactured by Serum Institute of India in Pune, which are being administered to frontline workers from January 16, under Emergency Use Authorisation.

Drug maker Dr Reddys recently said it will approach the Drug Regulator for the EUA for Russian vaccine Sputnik V in March.

Jaishankar said Prime Minister Narendra Modis’ idea was to establish the country as the “Pharmacy of the World”, taking advantage of the domestic capabilities and the way India emerged as IT leader during the Y2K issue.

Express Subscription Check out our special pricing for international readers when the offer lasts

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest India News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement